| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| enGene Holdings Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 153,000 | 30 Nov 2023 | Direct | ||
| Rain Oncology Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 110,000 | 15 Feb 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ENGN | enGene Holdings Inc. | 30 Nov 2023 | 1 | $0 | 4 | Chief Medical Officer | 04 Dec 2023, 17:55 |
| ENGN | enGene Holdings Inc. | 31 Oct 2023 | 0 | $0 | 3 | Chief Medical Officer | 31 Oct 2023, 18:00 |
| /report/000110465923023388-bryce-richard-paul-2023-02-15 | Rain Oncology Inc. | 15 Feb 2023 | 1 | $0 | 4 | Chief Medical Officer | 17 Feb 2023, 17:21 |
| /report/000089924322004836-bryce-richard-paul-2022-01-07 | Rain Therapeutics Inc. | 07 Jan 2022 | 1 | $0 | 4 | Chief Medical Officer | 04 Feb 2022, 15:40 |